Thank you for supporting journalism at your local newspaper. This article is available exclusively for our subscribers, who help fund our work at Navarre Press.
News
Patient safeguards needed for biosimilar development
(Family Features) Thanks to a provision in the Patient Protection and Affordable Care Act, efforts are underway to streamline licensing for medications known as “biosimilars,” which are similar – but not identical – to cutting-edge biologic medicines. However, the development has some concerned about patient safety, especially among older Americans who tend to suffer from more chronic diseases, such as cancer, diabetes, and heart disease.
Man with nurse
The remainder of this article is available only for our website subscribers, who help fund our mission of keeping you updated on news you want and need to know. You can become a subscriber for as little as $5.67 a month.
